■ Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic?
Luciano F. Drager, Andrea Pio-Abreu, Renato D. Lopes, Luiz A. Bortolotto
Curr Hypertens Rep. 2020; 22(6): 43
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292934/
■ COVID-19 and arterial hypertension: Hypothesis or evidence?
M Tadic, C Cuspidi, G Grassi
The Journal of Clinical Hypertensionn 2020, vol 22 (7): 1120-1126
https://onlinelibrary.wiley.com/doi/10.1111/jch.13925
■ COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?
M Tadic, C Cuspidi
The Journal of Clinical Hypertension 2020, vol 22 (11): 1984-1986
https://onlinelibrary.wiley.com/doi/10.1111/jch.14045
■ Isolate nocturnal hypertension: What do we know and what can we do?
Marijana Tadic, Cesare Cuspidi, Guido Grassi, Giuseppe Mancia
Integr Blood Press Control. 2020; 13: 63–69
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183347/
■ To whom recommend intensive treatment for hypertension?
Massimo Volpe, Giovanna Gallo
Eur Heart J Suppl. 2020 Jun; 22(Suppl E): E167–E17
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270960/
■ Is resistant hypertension an independent predictor of all-cause mortality in individuals type 2 diabetes? A prospective cohort study
Anna Solini, Giuseppe Penno, Emanuela Orsi, et al
for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group
BMC Med. 2019; 17: 83
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482506/
■ Resistant hypertension: Where are we now and where do we go from here?
Mansur K Pathan, Debbie L Cohen
Integr Blood Press Control. 2020; 13: 83–93
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415451/
■ Afternoon blood pressure increase on home blood pressure measurement: a forgotten entity?
S Taguchi, K Tamura,
The Journal of Clinical Hypertension 2020, vol 22 (12): 2202-2203
https://onlinelibrary.wiley.com/doi/10.1111/jch.14078
■ Should elevated blood pressure be treated with antihypertensive drug therapy?
W S Aronow,
The Journal of Clinical Hypertensionn 2020, vol 22 (9): 1635-1637
https://onlinelibrary.wiley.com/doi/10.1111/jch.13981
■ Redefining diuretics use in hypertension: why select a thiazide-like diuretic?
Michel Burnier, George Bakris, Bryan Williams
J Hypertens. 2019 Aug; 37(8): 1574–1586.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615933/
■ Does arterial stiffness reflect cardiovascular risk in the very elderly?
H Tomiyama
The Journal of Clinical Hypertension 2020, vol 22 (12): 1216-1217
https://onlinelibrary.wiley.com/doi/10.1111/jch.13892
■ Is the association between sleep apnea and left ventricular hypertrophy obesity-independent?
C Cuspid, M Tadic, C Sala, G Grassi
The Journal of Clinical Hypertension 2020, vol 22 (7): 1282-1283
https://onlinelibrary.wiley.com/doi/10.1111/jch.13908
■ Does chronic kidney disease predict stroke risk independent of blood pressure? A systematic review and meta-regression
Dearbhla M. Kelly, Peter M. Rothwell
Stroke. 2019 Nov; 50(11): 3085–3092.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824504/
■ Wrist devices with both accuracy and feasibility, new option to measure nocturnal blood pressure?
R Heo, J Shin
The Journal of Clinical Hypertension 2020, vol 22 (6): 979-980
https://onlinelibrary.wiley.com/doi/10.1111/jch.13862
■ Did the 2017 ACC/AHA blood pressure guideline get it wrong in reducing the diastolic threshold to define hypertension from 90 to 80 mmHg?
B P McGrath, J W McEvoy
The Journal of Clinical Hypertension 2020, vol 22 (7): 1200-1201
https://onlinelibrary.wiley.com/doi/10.1111/jch.13899
■ Neprilysin: a potential therapeutic target of arterial hypertension?
Juan Salazar, Joselyn Rojas-Quintero, Clímaco Cano et al
Curr Cardiol Rev. 2019 Feb; 16(1): 25–35.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062041/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: janeiro 2021